NEW YORK, July 27, 2026, 16:06 EDT — The U.S. regular session has ended.
- The stock ended the session at $5.18, rising 5.9% following a 16.6% decline last week.
- Monday brought back around $180 million in implied equity value, though approximately 70% of last week’s losses persist.
- PowerCo’s payment cap dropped by roughly $55.6 million, significantly less than the amount wiped from its market value.
QuantumScape Corporation NASDAQ:QS recovered on Monday following two sessions of losses after its results. Shares of the solid-state battery company ended the day at $5.18, gaining 5.9%.
The key number is the valuation gap yet to be closed. QuantumScape finished the previous week at $4.89, having dropped from $5.86.
With 619.1 million shares outstanding, the drop wiped out approximately $600 million in value. On Monday, the stock’s rebound recovered close to $180 million, about 30% of what was lost.
The weekly drop was close to 11 times greater than the PowerCo payment cut. This suggests a broader reevaluation of timing and execution risk.
| Comparison | Amount | Investor reading |
|---|---|---|
| July 17 closing price | $5.86 | Weekly reference point |
| July 24 closing price | $4.89 | Fell 16.6% |
| July 27 closing price | $5.18 | Rose 5.9% Monday |
| Last week’s implied value decrease | About $600 million | 10.8 times the reduction in payout |
| Implied value recovered on Monday | About $180 million | Recovered about 30% |
| PowerCo reduction in payment ceiling | About $55.6 million | Dropped from roughly $131 million to $75.4 million |
Volkswagen AG’s ETR:VOW3 battery subsidiary, PowerCo, adjusted its program structure earlier this month. Instead of cost reimbursements, payments will now be linked to specific cell-delivery and validation milestones.
The program limit has been set at $75.4 million, factoring in payments that PowerCo has previously made.
Chief Financial Officer Kevin Hettrich stated that decreased project spending is expected to balance the drop in payments. He predicted a “net neutral financial impact in terms of cash.” Investing.com
The rest of the PowerCo payments were not individually specified. The company left its possible $130 million royalty prepayment at the same level. This prepayment continues to depend on achieving technical milestones and finalizing cell format terms.
The stock move reflected more than just the direct cash impact. PowerCo is still the sole partnership QuantumScape holds with a defined goal to bring its technology to market.
Second-quarter results highlight that caution remains warranted. Customer billings stood at $10.8 million, while adjusted EBITDA reflected a $64.2 million loss.
Billings represented approximately 17 cents for every dollar of adjusted EBITDA loss. Management emphasized that billings do not qualify as revenue under U.S. accounting standards.
Despite this, billings for the first half were $21.8 million, topping the total of $19.5 million reported for the whole of 2025. As of June 30, liquidity was $859 million.
QuantumScape reaffirmed its projection for an adjusted EBITDA loss of $250 million to $275 million in 2026. The company reduced its capital expenditure outlook to a range of $27 million to $37 million.
The focus of operations is now on the automated Eagle pilot line. Key equipment is running with more than 90% uptime, and management has set a goal to double cell production in the second half.
Chief Executive Siva Sivaram reaffirmed PowerCo’s output target for 2029. “We have not announced any change from our original plans,” he stated. Investing.com
Wall Street sentiment is cautious. StockAnalysis monitors nine analysts, who maintain a consensus Hold rating and set an average price target of $6.66.
QuantumScape shares rebounded on Monday absent any new regulatory disclosure. The most recent filing from the company was Friday’s quarterly update, with the official calendar showing no scheduled investor event as of market close.
Risks are still elevated. PowerCo payments and the royalty prepayment hinge on achieving technical milestones. QuantumScape has yet to post operating revenue, and production setbacks may impede its commercialization schedule.
Related articles: NASDAQ:QS
